Antazoline
Back to searchMolecule Structure
Scientific Name
Antazoline
Description of the Drug
Antazoline is an antihistamine agent used for the symptomatic treatment of nasal congestion and allergic conjunctivitis.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB08799
http://www.drugbank.ca/drugs/DB08799
Brand Name(s)
Antaz sulf, Vasocon-a
Company Owner(s)
Novartis Pharmaceuticals Corp
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Histamine H1 receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL231 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL9437 | ||
Human Metabolome Database | HMDB0015689 | ||
DrugBank | DB08799 | ||
PubChem: Thomson Pharma | 15070645 | ||
PubChem | 2200 | ||
Mcule | MCULE-7710878667 | ||
LINCS | LSM-6023 | ||
Nikkaji | J4.345A | ||
BindingDB | 76862 | ||
EPA CompTox Dashboard | DTXSID3022613 | ||
DrugCentral | 224 | ||
ChemicalBook | CB8667315 | ||
Guide to Pharmacology | 7116 | ||
rxnorm | ANTAZOLINE HYDROCHLORIDE | ANTAZOLINE | ANTAZOLINE PHOSPHATE |
ChEBI | 84115 | ||
ZINC | ZINC000000057204 |